Airway diseases
Thoracic oncology
Thematic poster
Diagnostics and biomarkers in lung cancer
Methods :
Cell and molecular biology, Surgery, Imaging, Endoscopy and interventional pulmonology, Epidemiology, General respiratory patient care
Chairs
R. Lee
Beaconsfield, Buckinghamshire
(United Kingdom)
Detection of micrometastases in mediastinal lymph nodes by haematological analyser and flow cytometry-pilot study.
I. Kwiecień(Warszawa, Poland)
COI
1
Computed tomography derived body composition analysis predicts cachexia and survival in patients with lung cancer
T. Kerkhoff(Essen, Germany)
COI
2
Volatile biopsies in personalized molecular diagnosis and follow-up of lung adenocarcinoma
O. Goksel(Izmir (Bornova), Turkey)
COI
3
Proportion of mediastinal lymph nodes that cross predefined borders on the IASLC map.
Ø. Yksnøy(Ålesund, Norway)
COI
4
Mediastinal "deep freeze" - transcarinal lymph node cryobiopsy
E. Gershman(Givataim, Israel)
COI
5
Malignant pleural effusion (MPE) diagnosis with medical thoracoscopy (MT) compared with conventional approaches
I. Karampinis(Athens, Greece)
COI
6
Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment
D. Gompelmann(Vienna, Austria)
COI
7
A comparison of the biopsy techniques for tissue subtyping and molecular profiling in non-small -call lung cancer: is tissue an issue?
M. Hassan(Alexandria, Egypt)
COI
8
Clarifying oligometastatic non-small cell lung cancer in patients with local ablative therapies for oligoprogression after tyrosine kinase inhibitors
D. Hyun(Seoul, Republic of Korea)
COI
9
N2 institutional consensus on Non-Small Cell Lung Cancer (NSCLC)
H. Eid(Beirut, Lebanon)
COI
10
Detection of EGFR mutation status on pleural fluid samples in patient with lung adenocarcinoma
A. Navarra(Watford, United Kingdom)
COI
11
Impact of COVID-19 (C19) on EBUS-TBNA
A. Lal(Solihull (West Midlands), United Kingdom)
COI
12
Trans thoracic CT‑guided fine‑needle biopsy of pulmonary lesions, predictive factors for complications and accuracy of diagnosis
13
. . .
